Various types of inhalers exist for aerosolizing liquids. For example, U.S. Pat. No. 5,586,550, incorporated herein by reference, describes an inhaler that comprises a dispensing apparatus in which a membrane with tapered apertures is vibrated such that liquid in contact with a rear face of the membrane is dispensed from a front face of the membrane as an aerosol. Other examples of single dose inhaler systems and medicaments that may be aerosolized are described in U.S. Patent Publication Nos. 2011/0168172 and 2011/0168170, the disclosures of which are herein incorporated by reference.
One aspect of such inhalers is the need to supply a metered amount of liquid medicament to the dispensing apparatus so that the metered amount may be aerosolized and delivered to the patient's lungs. However, delivering a known quantity of a liquid medicament (that typically must be stored in a sterile environment) has proven to be challenging, particularly when the metered quantity needs to be dispensed in a controlled and repeatable fashion. Hence, this invention relates to ways for delivering such medicaments to inhalers for subsequent aerosolizing.
One embodiment provides a method for supplying a metered amount of a liquid medicament to an aerosolizing device in a repeatable manner. The method utilizes an aerosolization device comprising a housing having a mouthpiece, a vibratable member within the housing and disposed to eject liquid droplets through the mouthpiece, a reservoir to hold the liquid medicament until aerosolized by the vibratable member, and an opening in the housing and in communication with the chamber. While described in connection with one specific type of inhaler, it will be appreciated that other types of aerosolization devices could be used with the methods described herein.
To supply a metered amount of liquid medicament, a dispenser is used that comprises an elongate dispenser body having a proximal end and a tip at a distal end through which a liquid medicament is dispensed. The dispenser further comprises a dispensing mechanism that operates to dispense a metered quantity of the liquid medicament from the tip each time the dispenser body is compressed.
One critical factor of the method is the manner in which the dispenser is held and operated by a user. To facilitate dispensing, the dispenser may be grasped with one hand such that the fingers wrap around the dispenser body, with the thumb closest to the proximal end and the last or pinky finger closest to the tip. The tip of the dispenser is inserted into the opening in the housing. Then, while grasping the dispenser in the manner described, the elongate body is forced toward the tip to cause the dispenser body to compress, thereby operating the dispensing mechanism and causing a metered quantity of the liquid medicament to eject into the chamber each time the dispenser body is compressed.
Because the prescription may call for more medicament than can be supplied with a single ejection from the dispenser, the process may be repeated for as many times as is needed to supply the prescribed amount into the chamber. This may be done with a “pumping action” where the user “pumps” the dispenser (causing it to compress with each pump), until the correct number of pumps have been supplied. For example, if the prescription calls for a certain volume of the liquid medicament, the dispenser may be pumped five times, with each pump dispensing a droplet having a metered volume of one-fifth the total volume.
In some cases, the tip may include at least one alignment feature that assists to keep the dispenser generally perpendicular to the housing while dispensing the liquid medicament. Once the metered amount has been dispensed into the chamber, the vibratable member is actuated to eject the dispensed liquid medicament as an atomized spray.
In another embodiment, the invention provides an exemplary aerosolization system. The system includes an aerosolization device comprising a housing having a mouthpiece, a vibratable member within the housing and disposed to eject liquid droplets through the mouthpiece, a reservoir to hold the liquid medicament until aerosolized by the vibratable member, and an opening in the housing that is in fluid communication with the chamber.
The system further includes a dispenser comprising an elongate dispenser body having a proximal end and a tip at a distal end through which a liquid medicament is dispensed. The dispenser further comprises a dispensing mechanism that operates to dispense a metered quantity of the liquid medicament from the tip each time the dispenser body is compressed. The dispenser is separate from the housing so that it may be manually interfaced with the aerosolization device.
Further, the opening defines an interface that engages with the tip such that when the tip is inserted into the opening, the interface stabilizes the dispenser in an upright orientation outside of the housing to permit the dispenser to be grasped with one hand to dispense the medicament. For example, this orientation permits a user to wrap the fingers around the dispenser body, with the thumb closest to the proximal end and the last finger closest to the tip, and while grasping the dispenser, forcing the elongate body toward the tip to cause the dispenser body to compress, thereby operating the dispensing mechanism and causing a metered quantity of the liquid medicament to eject into the chamber each time the dispenser body is compressed.
In one important aspect, the tip may include at least one alignment feature that assists to keep the dispenser generally perpendicular to the top surface of the housing while dispensing the liquid medicament. This alignment feature may comprise a circular step around the tip, a plurality of tabs protruding from the tip, and the like.
In yet another embodiment, the invention provides an exemplary method for supplying a metered amount of a liquid medicament to an aerosolizing device. The method utilizes an aerosolization device comprising a housing having a mouthpiece, a vibratable member within the housing and disposed to eject liquid droplets through the mouthpiece, and a reservoir to hold the liquid medicament until aerosolized by the vibratable member. The housing also includes a top surface and an opening in the top surface of the housing. The opening is in fluid communication with the chamber.
The method also utilizes a dispenser that comprises an elongate dispenser body having a proximal end and a tip at a distal end through which a liquid medicament is dispensed. The dispenser further comprises a dispensing mechanism that operates to dispense a metered quantity of the liquid medicament from the tip each time the dispenser body is compressed.
With this configuration, the tip is inserted into the opening in the housing such that the dispenser body is generally perpendicular to the top surface of the housing and is seated within the opening such that the dispenser body is self-standing outside of the housing. In this orientation, the dispenser body may be compressed to operate the dispensing mechanism and cause a metered quantity of the liquid medicament to eject into the chamber each time the dispenser body is compressed.
The dispenser may be repeatedly compressed to dispense multiple metered quantities of the liquid medicament into the chamber. Further, the tip may include one or more alignment features that assist to keep the dispenser generally perpendicular to the housing while dispensing the liquid medicament so that it may be aerosolized.
Certain aspects of the invention relate to techniques for dispensing metered quantities of a liquid medicament into an aerosolizing apparatus, also referred to as an inhaler. Although useful with a wide variety of aerosolizing devices, in some cases the liquid will be dispensed into an aerosolizing apparatus comprising a housing defining a dispensing outlet or mouthpiece, a vibratable membrane or mesh having a front face exposed at the outlet and a rear face for receiving a liquid to be dispensed, and a vibrating mechanism connected to the housing and operable to vibrate the membrane to dispense aerosol of the liquid through the membrane.
A variety of containers or dispensers may be used to store the liquid medicament, then to deliver a metered quantity of the liquid into a reservoir where it will contact the rear face of the membrane. In this way, a metered quantity of liquid is dispensable at the outlet or mouthpiece by operating the vibrating mechanism for an operating period sufficient to completely aerosolize the metered quantity at the rear face. The containers or dispensers will typically have a sealed region where the liquid is stored and a mechanism for dispensing a metered amount of liquid each time the mechanism is operated. For example, the container may be compressed or pumped to eject a droplet of a known volume.
Exemplary aerosol generators that may be used in such inhalers are also described in U.S. Pat. Nos. 5,164,740; 6,629,646; 6,926,208; 7,108,197; 5,938,117; 6,540,153; 6,540,154; 7,040,549; 6,921,020; 7,083,112; 7,628,339; 5,586,550; 5,758,637; 6,085,740; 6,467,476; 6,640,804; 7,174,888; 6,014,970; 6,205,999; 6,755,189; 6,427,682; 6,814,071; 7,066,398; 6,978,941; 7,100,600; 7,032,590; 7,195,011, and in U.S. Patent Publication Nos. 2011/0168172 and 2011/0168170, all incorporated herein by reference. These references describe exemplary aerosol generators and ways to manufacture such aerosol generators. Each are incorporated by reference for at least these features. The aerosol generators may comprise vibratable membranes having tapered aperture with a size in the range from about 3 μm to about 8 μm, preferably from about 3 μm to about 6 μm, and in some cases around 4 μm. The membrane may be domed shaped and be vibrated by an annular piezoelectric element that circumscribes the apertures. The diameter of the membrane may be in the range from about 5 mm to about 8 mm. The membrane may also have a thickness in the range from about 50 microns to about 70 microns. Typically, the membrane will be vibrated at a frequency in the range from about 50 kHz to about 150 kHz.
A variety of liquid medicaments may be dispensed from the container. For example, the liquid medicament may comprise an insulin formulation, such as a preservative free insulation, including any of those described in U.S. Patent Publication No. 2011/0168170, previously incorporated by reference. For example, a preservative free insulin formulation that may be dispensed may be free of any preservatives, including phenol, metacresol, chloro-cresol, thymol and mixtures thereof or the like. The absence of such preservatives enable the formulations to be aerosolized as a liquid spray using a vibrating mesh or aperture plate that operates at high frequencies. The absence of such preservatives permits a dosage of the formulation to come into contact with the vibrating mesh without substantial foaming of the formulation. In turn, the formulation may be aerosolized more quickly. Further, substantially all of the liquid is able to be aerosolized. Such formulations contain water in major and human insulin in minor amount. The formulations may also include various concentrations of human insulin. For example, the concentrations may be in the range from about 100 IU insulin/ml of formulation to about 1200 IU insulin/ml of formulation, and more preferably from about 200 IU insulin/ml of formulation to about 800 IU insulin/ml of formulation. In addition to water and human insulin, the formulations may also include zinc, acetate, chloride and sodium. The zinc ion and acetate ion come from the drug substance, e.g., the insulin. The chloride ion and sodium ion are added during dissolution of the insulin and adjustment of the pH. Merely by way of example, the NaCl concentration may be about 20 mM for an 800 IU insulin/ml formulation, about 10 mM for a 400 IU insulin/ml formulation, and about 5 mM for a 200 IU insulin/ml formulation.
Other liquid medicaments may also be dispensed. For example, such medicaments could include other protein formulations, asthma and COPD treatments, vaccines and pain relief treatments.
Referring now to the Figures, one exemplary method for dispensing a metered amount of medicament into an inhaler will be described. Shown in
In one embodiment, the liquid to be aerosolized is stored in a dispenser 30 that is best illustrated in
Tip 36 includes a shoulder 40 in the shape of an annular or circular step that serves as a stop to prevent further insertion of tip 34 into opening 20. Shoulder 40 is inset by a distance that is sufficient so that it not only serves as a stop by also permits tip 36 to seat within opening 20 in a stable position that is generally vertical to the top surface 13 of housing 12. As such, once dispenser 30 is placed into opening 20, it will be self-standing in a generally vertical orientation. This position permits a user to easily grasp the disperser 30 when ready to dispense a unit volume of the liquid to the aerosol generator. Although shown with a shoulder, other seating mechanisms could be used, such as a taper that matches with the taper of opening 20, protruding tabs or wings, detents, and the like.
One exemplary technique for operating dispenser 30 is illustrated in
As best shown in
By holding the dispenser 30 in the manner shown, this pumping action may easily occur. This is in contrast to a nasal spray dispenser, that is typically actuated in an upright manner by carefully and simultaneously compressing the proximal end with the middle and index finger (with the tip extending between the fingers) to the distal end of the dispenser container, that is held under equal pressure by the thumb. With this type of nasal sprayer, the spray occurs when sufficient pressure is applied equally to both ends. In contrast, dispenser 30 can be easily actuated by applying pressure solely to the distal end of the dispenser when the tip is engaged with the inhaler device. The inhaler device and mating features are constructed so that a metered amount of medicament is consistently delivered from the dispenser into the device and the user may do so with unregulated pressure, provided the force is greater than or equal to that required to compress the dispenser throughout its full range. If the inhaler device is loaded while placed on a table or any other freely supported surface, the force required to compress the dispenser into the device to the point of actuation is reduced by 50% when compared to the amount of force required to disperse a volume of liquid when holding both the device and dispenser (without the aid of a support surface).
The invention has now been described in detail for purposes of clarity and understanding. However, it will be appreciated that certain changes and modifications may be practiced within the scope of the appended claims.
This application is a continuation of U.S. Nonprovisional application Ser. No. 13/830,511, filed Mar. 14, 2013, which is a nonprovisional application claiming the benefit of U.S. Provisional Application No. 61/624,531, filed Apr. 16, 2012, the complete disclosures of which are herein incorporated by reference. This application is a continuation-in-part of U.S. Nonprovisional application Ser. No. 15/165,662, filed May 26, 2016, which is a continuation of U.S. patent application Ser. No. 14/606,623, filed on Jan. 27, 2015, now U.S. Pat. No. 9,545,488, which is a continuation of U.S. patent application Ser. No. 14/039,254, filed on Sep. 27, 2013, now U.S. Pat. No. 9,004,061, which is a continuation of U.S. patent application Ser. No. 13/004,662, filed on Jan. 11, 2011, now U.S. Pat. No. 8,950,394, which claims priority from U.S. Provisional Application No. 61/335,769, filed on Jan. 12, 2010, the complete disclosures of which are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1947310 | Sample et al. | Feb 1934 | A |
2463922 | Turner | Mar 1949 | A |
3789843 | Armstrong et al. | Feb 1974 | A |
3874380 | Baum | Apr 1975 | A |
4564129 | Urban et al. | Jan 1986 | A |
4694977 | Graf et al. | Sep 1987 | A |
5060642 | Gilman | Oct 1991 | A |
5164740 | Ivri | Nov 1992 | A |
5261601 | Ross et al. | Nov 1993 | A |
5333106 | Lanpher et al. | Jul 1994 | A |
5347998 | Hodson et al. | Sep 1994 | A |
5363842 | Mishelevich et al. | Nov 1994 | A |
5364838 | Rubsamen | Nov 1994 | A |
5385180 | Wittman et al. | Jan 1995 | A |
5479920 | Piper et al. | Jan 1996 | A |
5487378 | Robertson et al. | Jan 1996 | A |
5515842 | Ramseyer et al. | May 1996 | A |
5586550 | Ivri et al. | Dec 1996 | A |
5672581 | Rubsamen et al. | Sep 1997 | A |
5694919 | Rubsamen et al. | Dec 1997 | A |
5743250 | Gonda et al. | Apr 1998 | A |
5758637 | Ivri et al. | Jun 1998 | A |
5809997 | Wolf | Sep 1998 | A |
5884620 | Gonda et al. | Mar 1999 | A |
5915378 | Lloyd et al. | Jun 1999 | A |
5938117 | Ivri | Aug 1999 | A |
5941240 | Gonda et al. | Aug 1999 | A |
6014970 | Ivri et al. | Jan 2000 | A |
6062212 | Davison | May 2000 | A |
6085740 | Ivri et al. | Jul 2000 | A |
6085753 | Gonda et al. | Jul 2000 | A |
6098615 | Lloyd et al. | Aug 2000 | A |
6131567 | Gonda et al. | Oct 2000 | A |
6164498 | Faughey | Dec 2000 | A |
6205999 | Ivri et al. | Mar 2001 | B1 |
6257454 | Ritsche | Jul 2001 | B1 |
6312665 | Modi | Nov 2001 | B1 |
6408854 | Gonda et al. | Jun 2002 | B1 |
6427682 | Klimowicz et al. | Aug 2002 | B1 |
6467476 | Ivri et al. | Oct 2002 | B1 |
6540153 | Ivri | Apr 2003 | B1 |
6540154 | Ivri et al. | Apr 2003 | B1 |
6629646 | Ivri | Oct 2003 | B1 |
6640804 | Ivri et al. | Nov 2003 | B2 |
6647987 | Gonda et al. | Nov 2003 | B2 |
6688304 | Gonda et al. | Feb 2004 | B2 |
6712762 | Lichter et al. | Mar 2004 | B1 |
6729327 | McFarland, Jr. | May 2004 | B2 |
6748946 | Rand et al. | Jun 2004 | B1 |
6755189 | Ivri et al. | Jun 2004 | B2 |
6790178 | Mault et al. | Sep 2004 | B1 |
6814071 | Klimowicz et al. | Nov 2004 | B2 |
6921020 | Ivri | Jul 2005 | B2 |
6926208 | Ivri | Aug 2005 | B2 |
6958691 | Anderson et al. | Oct 2005 | B1 |
6978941 | Litherland et al. | Dec 2005 | B2 |
7028686 | Gonda et al. | Apr 2006 | B2 |
7032590 | Loeffler et al. | Apr 2006 | B2 |
7040549 | Ivri et al. | May 2006 | B2 |
7066398 | Borland et al. | Jun 2006 | B2 |
7083112 | Ivri | Aug 2006 | B2 |
7100600 | Loeffler et al. | Sep 2006 | B2 |
7108197 | Ivri | Sep 2006 | B2 |
7117867 | Cox et al. | Oct 2006 | B2 |
7174888 | Ivri et al. | Feb 2007 | B2 |
7195011 | Loeffler et al. | Mar 2007 | B2 |
7219664 | Ruckdeschel et al. | May 2007 | B2 |
7448375 | Gonda et al. | Nov 2008 | B2 |
7451760 | Denyer et al. | Nov 2008 | B2 |
7600511 | Power et al. | Oct 2009 | B2 |
7600512 | Lee et al. | Oct 2009 | B2 |
7628339 | Ivri et al. | Dec 2009 | B2 |
7683029 | Hindle et al. | Mar 2010 | B2 |
7819115 | Sexton et al. | Oct 2010 | B2 |
7886783 | Rindy et al. | Feb 2011 | B2 |
8082918 | Jansen et al. | Dec 2011 | B2 |
8326964 | Chourey | Dec 2012 | B1 |
8736227 | Chadbourne et al. | May 2014 | B2 |
8950394 | Patton et al. | Feb 2015 | B2 |
9004061 | Patton et al. | Apr 2015 | B2 |
9180261 | Patton et al. | Nov 2015 | B2 |
9545488 | Patton et al. | Jan 2017 | B2 |
10525214 | Patton et al. | Jan 2020 | B2 |
11400241 | Patton et al. | Aug 2022 | B2 |
20010037805 | Gonda et al. | Nov 2001 | A1 |
20010039948 | Sexton et al. | Nov 2001 | A1 |
20020129813 | Litherland | Sep 2002 | A1 |
20030019493 | Narayan et al. | Jan 2003 | A1 |
20030041859 | Abrams et al. | Mar 2003 | A1 |
20030072740 | Milstein et al. | Apr 2003 | A1 |
20030101991 | Trueba | Jun 2003 | A1 |
20030150445 | Power | Aug 2003 | A1 |
20030150446 | Patel et al. | Aug 2003 | A1 |
20040100509 | Sommerer | May 2004 | A1 |
20040134494 | Papania et al. | Jul 2004 | A1 |
20040154617 | Enk | Aug 2004 | A1 |
20040223917 | Hindle et al. | Nov 2004 | A1 |
20040256488 | Loeffler et al. | Dec 2004 | A1 |
20050011514 | Power et al. | Jan 2005 | A1 |
20050030953 | Vasudevan et al. | Feb 2005 | A1 |
20050133024 | Coifman | Jun 2005 | A1 |
20050166913 | Sexton et al. | Aug 2005 | A1 |
20050172958 | Singer et al. | Aug 2005 | A1 |
20050240084 | Morice et al. | Oct 2005 | A1 |
20060239930 | Lamche et al. | Oct 2006 | A1 |
20060261084 | Grey et al. | Nov 2006 | A1 |
20070074722 | Giroux et al. | Apr 2007 | A1 |
20070113841 | Fuchs | May 2007 | A1 |
20070163572 | Addington | Jul 2007 | A1 |
20070209659 | Ivri et al. | Sep 2007 | A1 |
20080017188 | Pardonge et al. | Jan 2008 | A1 |
20080020794 | Garon et al. | Jan 2008 | A1 |
20080029083 | Masada et al. | Feb 2008 | A1 |
20080060641 | Smith et al. | Mar 2008 | A1 |
20080148193 | Moetteli | Jun 2008 | A1 |
20080184993 | Patel | Aug 2008 | A1 |
20080220747 | Ashkenazi et al. | Sep 2008 | A1 |
20080233053 | Gross et al. | Sep 2008 | A1 |
20080306794 | Cohen et al. | Dec 2008 | A1 |
20090025718 | Denyer | Jan 2009 | A1 |
20090095292 | Hamano et al. | Apr 2009 | A1 |
20090099065 | Madsen et al. | Apr 2009 | A1 |
20090140010 | Pruvot | Jun 2009 | A1 |
20090151718 | Hunter et al. | Jun 2009 | A1 |
20090156952 | Hunter et al. | Jun 2009 | A1 |
20090157037 | Iyer et al. | Jun 2009 | A1 |
20090194104 | Van Sickle | Aug 2009 | A1 |
20090241948 | Clancy | Oct 2009 | A1 |
20090301472 | Kim et al. | Dec 2009 | A1 |
20100075001 | Succar et al. | Mar 2010 | A1 |
20100094099 | Levy et al. | Apr 2010 | A1 |
20100153544 | Krassner et al. | Jun 2010 | A1 |
20100154793 | Kobayashi et al. | Jun 2010 | A1 |
20100180890 | Nobutani | Jul 2010 | A1 |
20100236545 | Kern | Sep 2010 | A1 |
20100250280 | Sutherland | Sep 2010 | A1 |
20100250697 | Hansen et al. | Sep 2010 | A1 |
20100319686 | Schennum | Dec 2010 | A1 |
20100326436 | Kaneko | Dec 2010 | A1 |
20110022350 | Chatterjee | Jan 2011 | A1 |
20110114089 | Andersen et al. | May 2011 | A1 |
20110125594 | Brown et al. | May 2011 | A1 |
20110168172 | Patton et al. | Jul 2011 | A1 |
20110225008 | Elkouh et al. | Sep 2011 | A1 |
20110246440 | Kocks et al. | Oct 2011 | A1 |
20110253139 | Guthrie et al. | Oct 2011 | A1 |
20120032901 | Kwon | Feb 2012 | A1 |
20120037154 | Gallem et al. | Feb 2012 | A1 |
20120069803 | Iwamura et al. | Mar 2012 | A1 |
20120116241 | Shieh | May 2012 | A1 |
20120144303 | Cricks et al. | Jun 2012 | A1 |
20120155987 | Watanabe | Jun 2012 | A1 |
20120285236 | Haartsen et al. | Nov 2012 | A1 |
20130155987 | Lan et al. | Jun 2013 | A1 |
20130318471 | Freyhult | Nov 2013 | A1 |
20140010187 | Huang et al. | Jan 2014 | A1 |
20140362831 | Young | Dec 2014 | A1 |
20150092590 | Zhu et al. | Apr 2015 | A1 |
20150196721 | Patton et al. | Jul 2015 | A1 |
20190015611 | Patton et al. | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
112012017177 | Oct 2020 | BR |
112014025878 | Apr 2022 | BR |
1062091 | Jun 1992 | CN |
2406684 | Nov 2000 | CN |
1303309 | Jul 2001 | CN |
2461580 | Nov 2001 | CN |
101080249 | Nov 2007 | CN |
101300041 | Nov 2008 | CN |
101316660 | Dec 2008 | CN |
101495168 | Jul 2009 | CN |
102740915 | Jan 2016 | CN |
111875 | Jun 1984 | EP |
311863 | Apr 1989 | EP |
2838593 | Feb 2015 | EP |
2838592 | May 2018 | EP |
2 835 435 | Aug 2003 | FR |
340395 | Jul 2016 | MX |
2188041 | Aug 2002 | RU |
2336906 | Oct 2008 | RU |
2460677 | Sep 2012 | RU |
9822290 | May 1998 | WO |
03030829 | Apr 2003 | WO |
2004028608 | Apr 2004 | WO |
2005065756 | Jul 2005 | WO |
2006062449 | Jun 2006 | WO |
2006006963 | Jun 2006 | WO |
2007047948 | Apr 2007 | WO |
2008121610 | Oct 2008 | WO |
2009111612 | Sep 2009 | WO |
2010002421 | Jan 2010 | WO |
2010066714 | Jun 2010 | WO |
2010141803 | Dec 2010 | WO |
2011088070 | Jul 2011 | WO |
2011130183 | Oct 2011 | WO |
Entry |
---|
“ON” Oxforadictinaries.com., Oxford Dictionaries, 2016, Web. Jun. 21, 2016, 1 page. |
Australian Application No. 2011205443, First Examination Report dated Mar. 13, 2015, 3 pages. |
Chinese Application No. 201180005839.9, Notice of Decision to Grant dated Sep. 18, 2015, 4 pages (3 pages for the original document and 1 page for the English translation). |
Chinese Application No. 201380031812.6, Office Action dated Apr. 19, 2016, 6 pages. |
Indian Application No. 1921/MUMNP/2012, First Examination Report dated May 10, 2019, 7 pages. |
International Application No. PCT/US2011/020925, International Preliminary Report on Patentability dated Jul. 26, 2012, 6 pages. |
International Application No. PCT/US2011/020925, International Search Report and Written Opinion dated Mar. 14, 2011, 7 pages. |
International Application No. PCT/US2013/034359, International Preliminary Report on Patentability dated Oct. 30, 2014, 7 pages. |
Mexican Application No. MX/A/2012/008010, Office Action dated Feb. 12, 2015, 2 pages. |
Mexican Application No. MX/A/2012/008010, Office Action dated Jul. 15, 2014, 5 pages. |
Russian Application No. 2012134422, Notice of Decision to Grant dated Feb. 17, 2015, 13 pages (8 pages for the original document and 5 pages for the English translation). |
Russian Application No. 2014145835, Office Action dated Feb. 6, 2017, 7 pages. |
Russian Application No. 2014145836, Notice of Decision to Grant dated Jul. 27, 2017, 8 pages. |
U.S. Appl. No. 13/004,662, Advisory Action dated Sep. 6, 2013, 3 pages. |
U.S. Appl. No. 13/840,588, Final Office Action dated Sep. 11, 2015, 30 pages. |
U.S. Appl. No. 13/840,588, Final Office Action dated Jun. 30, 2016, 32 pages. |
U.S. Appl. No. 3/840,588, Non-Final Office Action dated Feb. 24, 2016, 15 pages. |
U.S. Appl. No. 13/840,588, Non-Final Office Action dated Feb. 9, 2017, 25 pages. |
BR1120140258783 received an office action dated Jan. 14, 2020, 7 pages. |
Liu, F-Y, “Pulmonary Delivery Of Free Liposomal Insulin,” Pharmaceutical Research, Kluwer Academic Publishers, New York, NY, vol. 10, No. 2, Feb. 1, 1993, 5 pages. |
International Search Report and Written Opinion of PCT/US2011/020925 dated Mar. 14, 2011, 7 pages. |
International Search Report and Written Opinion of PCT/US2011/020926 dated Mar. 14, 2011, 11 pages. |
International Search Report and Written Opinion of PCT/US2013/034359 dated Jun. 28, 2013, 35 pages. |
International Search Report (PCT/US/057971) dated Dec. 13, 2013; 3 pages. |
European Search Report of EP 11733287 dated Jul. 12, 2013, 12 pages. |
European Search Report for European Patent Application 11733286.6, dated Aug. 4, 2015, 5 pages. |
EP Application No. 11733286.6 filed Jan. 12, 2011 received an Office Action dated Mar. 20, 2018, 4 pages. |
Australian Examination Report of related Australian application No. 2011205443 dated Mar. 13, 2015, 4 pages. |
Office Action of related Chinese Application No. 201180005839.9 dated Jun. 17, 2014, 16 pages. |
Office Action of related Chinese application No. 201180005839.9 dated Mar. 3, 2015, 13 pages. |
Office Action of related Mexican application No. MX/a/2012/008010 dated Jul. 15, 2014, 5 pages. |
Office Action of related Mexican Patent Application No. MX/a/2012/008010 dated Nov. 12, 2014, 6 pages. |
Office Action of related Mexican Application No. MX/a/2012/008010 dated Feb. 12, 2015, 2 pages. |
Office Action of related Russian Application No. 2012134422 dated Oct. 20, 2014, 5 pages. |
U.S. Appl. No. 15/165,662 received a Final Office Action dated Jan. 30, 2017, 16 pages. |
U.S. Appl. No. 15/165,662 received a Final Office Action dated May 7, 2018, 18 pages. |
U.S. Appl. No. 15/165,662 received a Non-Final Office Action dated Aug. 8, 2016, 16 pages. |
U.S. Appl. No. 15/165,662 received a Non-Final Office Action dated Aug. 30, 2017, 16 pages. |
U.S. Appl. No. 15/165,662 received a Non-Final Office Action dated Sep. 6, 2018, 18 pages. |
U.S. Appl. No. 15/165,662 received an Advisory Action dated Jul. 10, 2017, 3 pages. |
U.S. Appl. No. 15/165,662 received an Advisory Action dated Jul. 24, 2018, 3 pages. |
U.S. Appl. No. 14/606,623 received a Notice of Allowance dated Dec. 14, 2016 4 pages. |
U.S. Appl. No. 14/606,623 received a Notice of Allowance dated Apr. 18, 2016, 8 pages. |
U.S. Appl. No. 14/606,623 received a Non-Final Office Action dated Mar. 8, 2016, 7 pages. |
U.S. Appl. No. 14/039,254 received a Non-Final Office Action dated Feb. 10, 2014, 16 pages. |
U.S. Appl. No. 14/039,254 received a Final Office Action dated Jun. 11, 2014, 18 pages. |
U.S. Appl. No. 14/039,254 received a Notice of Allowance dated Mar. 18, 2015, 2 pages. |
U.S. Appl. No. 14/039,254 received Notice of Allowance dated Dec. 24, 2014, 14 pages. |
U.S. Appl. No. 14/039,254 received an Advisory Action dated Sep. 10, 2014, 3 pages. |
U.S. Appl. No. 13/004,662 received a Notice of Allowance dated Nov. 24, 2014, 13 pages. |
U.S. Appl. No. 13/004,662 received a Non-Final Office Action dated Apr. 18, 2014, 14 pages. |
U.S. Appl. No. 13/004,662 received a Non-Final Office Action dated Oct. 10, 2013, 14 pages. |
U.S. Appl. No. 13/004,662 received a Non-Final Office Action dated Jan. 22, 2013, 9 pages. |
U.S. Appl. No. 13/004,662 received a Final Office Action dated Aug. 22, 2014, 16 pages. |
U.S. Appl. No. 13/004,662 received a Final Office Action dated Jul. 18, 2013, 16 pages. |
U.S. Appl. No. 13/004,662 received an Advisory Action dated Sep. 6, 2013, 3 pages. |
U.S. Appl. No. 13/830,551 received a Non-Final Office Action dated Feb. 9, 2018, 23 pages. |
U.S. Appl. No. 13/830,551 received a Non-Final Office Action dated May 26, 2017, 18 pages. |
U.S. Appl. No. 13/830,551 received a Non-Final Office Action dated Apr. 11, 2016, 14 pages. |
U.S. Appl. No. 13/830,551 received a Non-Final Office Action dated Feb. 27, 2015, 12 pages. |
U.S. Appl. No. 13/830,551 received a Final Office Action dated Sep. 10, 2018, 18 pages. |
U.S. Appl. No. 13/830,551 received a Final Office Action dated Oct. 3, 2017, 20 pages. |
U.S. Appl. No. 13/830,551 received a Final Office Action dated Sep. 22, 2016, 16 pages. |
U.S. Appl. No. 13/830,551 received a Final Office Action dated Jul. 31, 2015, 14 pages. |
U.S. Appl. No. 13/830,511 received an Final Office Action dated Oct. 30, 2015, 45 pages. |
U.S. Appl. No. 13/830,511 received an Final Office Action dated Jul. 26, 2016, 26 pages. |
U.S. Appl. No. 13/830,511 received an Final Office Action dated Jan. 8, 2018, 38 pages. |
U.S. Appl. No. 13/830,511 received an Non-Final Office Action dated Apr. 5, 2017, 29 pages. |
U.S. Appl. No. 13/830,511 received an Non-Final Office Action dated Jun. 4, 2015, 36 pages. |
U.S. Appl. No. 13/830,511 received an Non-Final Office Action dated Mar. 11, 2016, 45 pages. |
U.S. Appl. No. 13/830,511 received an Non-Final Office Action dated May 15, 2018, 26 pages. |
U.S. Appl. No. 13/830,511 received an Non-Final Office Action dated Mar. 16, 2015, 27 pages. |
European Application No. EP13778248.8 received an Extended European Search report dated Oct. 26, 2015, 12 pages. |
European Application No. EP13778248.8 received a Notice of Decision to Grant dated May 4, 2018, 1 page. |
BR1120120171771 received an Office Action dated Feb. 27, 2020 3 pages. No English translation available. |
BR1120120171771 received a Notice of Allowance dated Jul. 30, 2020, 1 page, no English translation available. |
Brazilian Application No. BR1120140258783 received an Office Action, dated Oct. 13, 2021, 5 pages. |
U.S. Appl. No. 17/874,531, Non-Final Office Action, dated Mar. 2, 2023, 21 pages. |
Number | Date | Country | |
---|---|---|---|
20190015611 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
61624531 | Apr 2012 | US | |
61335769 | Jan 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14606623 | Jan 2015 | US |
Child | 15165662 | US | |
Parent | 14039254 | Sep 2013 | US |
Child | 14606623 | US | |
Parent | 13830511 | Mar 2013 | US |
Child | 16133484 | US | |
Parent | 13004662 | Jan 2011 | US |
Child | 14039254 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15165662 | May 2016 | US |
Child | 16133484 | US |